Genetic variations in influx transporter gene SLC22A1 are associated with clinical responses to imatinib mesylate among Malaysian chronic myeloid leukaemia patients-Reference-Cited by-同舟云学术

Genetic variations in influx transporter gene SLC22A1 are associated with clinical responses to imatinib mesylate among Malaysian chronic myeloid leukaemia patients

Published:2018-08-17 Issue:4 Volume:97 Page:835-842
ISSN:0022-1333
Container-title:Journal of Genetics
language:en
Short-container-title:J Genet

Author:

Makhtar Siti Maziras,Husin Azlan,Baba Abdul Aziz,Ankathil Ravindran

Funder

Universiti Sains Malaysia

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://link.springer.com/article/10.1007/s12041-018-0978-9/fulltext.html

Reference22 articles.

1. Angelini S., Soverini S., Ravegnini G., Barnett M., Turrini E., Thornquist M. et al. 2013 Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy. Haematologica 98, 193–200.

2. Baccarani M., Pileri S., Steegmann J. L., Muller M., Soverini S. and Dreyling M. 2012 Chronic myeloid leukemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 23, vii72–77.

3. Bazeos A., Marin D., Reid A. G., Gerrard G., Milojkovic D., May P. C. et al. 2010 hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia. Leukemia 24, 1243–1245.

4. Bixby D. and Talpaz M. 2009 Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance. Hematol. Am. Soc. Hematol. Educ. Program, 461–476.

5. Cao C., Li X., Liu T., Zhang L., Shen K. and Zhu H. 2015 Human organic cation transporter 1 protein levels of granulocytes can optimize imatinib therapy in patients with chronic myeloid leukemia. Acta Haematol. 133, 199–204.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine kinase inhibitors in cancers: Treatment optimization – Part II;Critical Reviews in Oncology/Hematology;2024-08

2. Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy;Cancer Drug Resistance;2024-07-18

3. Pharmacogenomics of Cancer Chemotherapy: Transporter Polymorphisms and Drug Response;Interdisciplinary Cancer Research;2024

4. Genetic Variants of ABC and SLC Transporter Genes and Chronic Myeloid Leukaemia: Impact on Susceptibility and Prognosis;International Journal of Molecular Sciences;2022-08-29

5. Pharmacogenetics of Drugs Used in the Treatment of Cancers;Genes;2022-02-07